| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $422K | +14.1% | +50.4% |
| Operating Income | -$422K | -14.1% | -50.3% |
| Interest Expense | $83K | +7.2% | -25.1% |
| Pre-tax Income | -$506K | -13.8% | -32.5% |
| Income Tax | $0 | — | — |
| Net Income | -$506K | -13.8% | -32.5% |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $28K | +220.8% | +315.1% |
| Total Assets | $28K | +220.8% | +315.1% |
| Current Liabilities | $6.4M | +6.1% | +28.5% |
| Stockholders' Equity | -$6.4M | -5.8% | -28.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$293K | -78.8% | — |
| Financing Cash Flow | $256K | +140.7% | — |